COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 232: Articles 2311-2320  | Next

Ineffectiveness of international travel restrictions to contain spread of the SARS-CoV-2 Omicron BA.1 variant: a continent-wide laboratory-based observational study from Africa
Fischer, C., Maponga, T. G., Yadouleton, A., Abilio, N., Aboce, E., Adewumi, P., Afonso, P., Akorli, J., Andriamandimby, S. F., Anga, L., Ashong, Y., Beloufa, M. A., Bensalem, A., Birtles, R., Magloire Boumba, A. L., Bwanga, F., Chaponda, M., Chibukira, P., Chico, R. M., Chileshe, J., Choga, W., Chongwe, G., Cisse, A., Cisse, F., D Alessandro, U., de Lamballerie, X., de Morais, J. F. M., Derrar, F., Dia, N., Diarra, Y., Doumbia, L., Drosten, C., Dussart, P., Echodu, R., Luedde, T., Eloualid, A., Faye, O., Feldt, T., Fruehauf, A., Gaseitsiwe, S., Halatoko, A., Ilouga, P.-V., Ismael, N., Jambou
10.1101/2024.02.27.24303356 — Posted: 2024-02-29
Implementing remote monitoring for COVID-19 patients in primary care
Koehler, S. M., Holtz, S., Chabiera, P. J., Dauletbaev, N., Deutsch, K., Oftring, Z. S., Lawin, D., Niekrenz, L., Euler, T., Gloeckl, R., Koczulla, R., Rohde, G., Dreher, M., Vogelmeier, C. F., Kuhn, S., Mueller, B. S.
10.1101/2024.02.27.24303073 — Posted: 2024-02-29
Evaluating the impacts of tiered restrictions introduced in England in December 2020 on covid-19 hospitalisations: a synthetic control study.
Zhang, X., Hungerford, D., Green, M., Garcia-Finana, M., Buchan, I., Barr, B.
10.1101/2024.02.28.24303487 — Posted: 2024-02-29
COVID-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021-2022: a repeated cross-sectional study
Tembo, T., Heilmann, E., Somwe, P., Bosomprah, S., Kalenga, K., Moyo, N., Kabamba, B., Seffren, V., Fwoloshi, S., Rutagwera, M.-R., Musunse, M., Mwiinga, L., Gutman, J. R., Hines, J. Z., Sikazwe, I.
10.1101/2024.02.27.24303454 — Posted: 2024-02-29
Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial
Williams, L. R., Emary, K. R., Phillips, D. J., Hay, J., Larwood, J. P., Ramasamy, M. N., Pollard, A. J., Grassly, N. C., Voysey, M.
10.1101/2024.02.28.24303505 — Posted: 2024-02-29
A structured course of disease dataset with contact tracing information in Taiwan for COVID-19 modelling
Wu, Y.-H., Nordling, T. E. M.
10.1101/2024.02.28.24303518 — Posted: 2024-02-29
Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in COVID-19: Evidence from a Northern Tanzanian Cohort
Kyala, N. J., Mboya, I., Shao, E., Sakita, F., Kilonzo, K. G., Shirima, L., Sadiq, A., Mkwizu, E., Chamba, N., Marandu, A., Muhali, S., Raza, F., Ndale, E., Bayo, D., Mujuni, D., Lyamuya, F.
10.1101/2024.02.28.24303516 — Posted: 2024-02-29
Virus-derived Synthetic Riboswitches for Real-time Coronaviruses Sensing in Live Cells
Zeng, L., Qi, L. S.
10.1101/2024.02.27.582433 — Posted: 2024-02-29
Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo
Tsugawa, Y., Furukawa, K., Ise, T., Takayama, M., Ota, T., Kuroda, T., Shano, S., Hashimoto, T., Konishi, H., Ishihara, T., Sato, M., Kamada, H., Fukao, K., Shishido, T., Takahashi, T., Nagata, S.
10.1101/2024.02.28.582480 — Posted: 2024-02-29
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination
Clark, J., Hoxie, I., Adelsberg, D., Sapse, I., Andreata-Santos, R., Yong, J., Amanat, F., Tcheou, J., Raskin, A., Singh, G., Gonzalez-Dominguez, I., Edgar, J., Bournazos, S., Sun, W., Carreno, J. M., Simon, V., Ellebedy, A., Krammer, F.
10.1101/2024.02.28.582613 — Posted: 2024-02-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).